COMy 2022 | How has the role of transplant changed with the introduction of CAR-T therapy?
Michele Cavo
• 17 May 2022
Michele Cavo, MD, PhD, Bologna University School of Medicine, Bologna, Italy, shares some insights into how the role of transplantation has changed with the introduction of CAR-T therapy. Prof. Cavo explains that head-to-head comparison trials are still needed to evaluate CAR-T versus transplant upfront, and also mentions the promise that CAR-T therapy has provided for high-risk patients and those with relapsed disease. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
